Casodex and Evista drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Casodex (bicalutamide) and Evista (raloxifene hydrochloride). Common drug interactions include abscess jaw among females and anxiety among males.

The phase IV clinical study analyzes what interactions people have when they take Casodex and Evista. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Casodex?

Casodex has active ingredients of bicalutamide. It is often used in prostate cancer. eHealthMe is studying from 10,725 Casodex users. Check the latest studies of Casodex.

What is Evista?

Evista has active ingredients of raloxifene hydrochloride. It is often used in osteoporosis. eHealthMe is studying from 25,891 Evista users. Check the latest studies of Evista.



On Jul, 25, 2026

12 people who take Casodex and Evista together, and have interactions are studied.

Casodex and Evista drug interactions.

What are the common drug interactions of Casodex and Evista, by gender? *:

female:

  1. Abscess jaw (tooth abscess or root abscess)
  2. Actinomycosis (infection that causes sores, or abscesses)
  3. Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
  4. Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
  5. Anaemia of chronic disease
  6. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  7. Anxiety
  8. Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
  9. Arthralgia (joint pain)
  10. Arthropathy

male:

  1. Anxiety
  2. Pain
  3. Insomnia (sleeplessness)
  4. Intervertebral disc protrusion (spinal disc protrusion)
  5. Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
  6. Lymphadenopathy (disease or enlargement of lymph nodes)
  7. Osteomyelitis (infection of bone)
  8. Osteonecrosis of jaw (death of bone of jaw)
  9. Pain in jaw
  10. Urinary incontinence (inability to control the flow of urine and involuntary urination)

What are the common drug interactions of Casodex and Evista, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
  2. Arthralgia (joint pain)
  3. Arthropathy
  4. Balanoposthitis (inflammation of the glands penis and the foreskin)
  5. Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
  6. Benign oesophageal neoplasm (benign (non-cancerous) tumours of the oesophageal)
  7. Bladder diverticulum (pouch like projection in the bladder, by birth or acquired)
  8. Blood testosterone decreased
  9. Bone erosion
  10. Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

  1. Abdominal pain upper
  2. Abscess jaw (tooth abscess or root abscess)
  3. Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)
  4. Bone swelling
  5. Cough
  6. Dental fistula
  7. Disability
  8. Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body)
  9. Dizziness
  10. Dyspepsia (indigestion)

What are the existing conditions these people have? *

  1. Hypogonadism (reduction or absence of hormone secretion or other physiological activity of the gonads (testes or ovaries)): 10 people, 83.33%
  2. Gynecomastia (enlargement of the gland tissue of the male breast): 10 people, 83.33%
  3. Osteopenia (a condition where bone mineral density is lower than normal): 8 people, 66.67%
  4. Metastases To Bone (cancer spreads to bone): 1 person, 8.33%
  5. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 8.33%
  6. Bone Pain: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Casodex and Evista?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Casodex and Evista:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Casodex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Evista:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Casodex and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Evista and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on bicalutamide and raloxifene hydrochloride (the active ingredients of Casodex and Evista, respectively), and Casodex and Evista (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: